Gefidoz 250 Tablet
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Gefitinib (250mg)
Overview Gefidoz 250 Tablet
Afirma 250mg tablets treat advanced non-small cell lung cancer. This medication is prescribed for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage and treatment duration are determined by your physician. Regular liver function monitoring may be recommended. Common adverse effects include nausea, diarrhea, dry skin, and appetite loss. Increased fluid intake can mitigate some side effects. Report any concerning or worsening side effects to your doctor immediately. Seek immediate medical attention for mouth sores, vision changes, or breathing problems. Women should utilize effective contraception throughout treatment and for one month post-treatment to prevent pregnancy. Always inform your physician of all other medications you are currently using.
Uses of Gefidoz 250 Tablet
Lung cancer (excluding small cell type)
Major Benefits of Gefidoz 250 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Gefidoz 250 Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Gefidoz 250 Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Gefidoz 250 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gefidoz 250 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
How Gefidoz 250 Tablet works:
Oncasin 250mg tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus hindering or reducing the growth of cancerous tissues.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gefidoz 250 Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Gefidoz 250 Tablet during pregnancy is considered unsafe due to established risks to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Gefidoz 250 Tablet use are likely incompatible. Preliminary human evidence indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Gefidoz 250 Tablets might impair your driving ability due to potential adverse effects.
KidneyCAUTION
Patients with severe kidney impairment should use Gefidoz 250 Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Gefidoz 250 Tablet in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Gefidoz 250 Tablet :
Omit any missed Gefidoz 250 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Gefidoz 250 Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently